Biotechnology Equipment: Biotechnology In India

biotechnology in india

This announcement fulfillsBharat Biotech's promiseof a $ 1 / dose vaccine to governments in low income countries and also realized nation's vision to "Make in India" vaccine. The company received commercial licensure and the vaccine is available for sale. Bharat Biotech International’s Rotavac, India’s first indigenously developed vaccine, is coming to the market at Rs 54 per dose, even lower than the incredible $1 price point promised two years ago. It prevents diarrhoea, which kills lakhs of children The global biotechnology industry is well established and rebounded strongly in the recent time. The Indian biotechnology sector has emerging market characteristics and is one of the fastest growing knowledge- based sectors, and is expected to play a key r Krishna Ella, chairman and managing director of Bharat Biotech, said they realised a dream by bringing out the first made in India molecule. "We have also maintained our pledge to offer Rotavac for $1 to governments in low income countries. Our vaccine is Krishna Ella, chairman and managing director of Bharat Biotech, said they realised a dream by bringing out the first made in India molecule. "We have also maintained our pledge to offer Rotavac for $1 to governments in low income countries. Our vaccine is Rotavac' is the third such vaccine available globally against Rotavirus. The Bharat Biotech India Limited, which was involved in the development and production of the vaccine, has given an undertaking to keep the cost of the vaccine at USD 1 (approx Rs 60 .

Krishna Ella, MD of Bharat Biotech, said it was a dream come through to make the first vaccine of Indian molecule. “We have also maintained our pledge to offer Rotavac for $1 to governments in low income countries. Our vaccine is affordable, safe and Rotavac', launched by Prime Minister Narendra Modi, is the third such vaccine available globally against Rotavirus.The Bharat Biotech India Limited, which was involved in the development and production of the vaccine, has given an undertaking to keep the The Bharat Biotech India Limited, which was involved in the development and production of the vaccine, has given an undertaking to keep the cost of the vaccine at US $1 (approx Rs 60) per dose, a PMO statement said, adding at the current prices Back in 2011, Indian company Bharat Biotech pledged to offer its rotavirus prospect at a price that undercut even discounted vaccines from GlaxoSmithKline ($GSK) and Merck ($MRK). Now, it's ready to make good on its promise. The country has rolled out .

biotechnology in india Bangalore INDIA BIO 2013 – driving force of the Biotech success 150 x 150 · 6 kB · jpeg
biotechnology in india Found on economictimes.indiatimes.com 80 x 80 · 4 kB · jpeg
biotechnology in india TITLE_IMG3 IMG_RES3
biotechnology in india TITLE_IMG4 IMG_RES4
biotechnology in india TITLE_IMG5 IMG_RES5
biotechnology in india TITLE_IMG6 IMG_RES6
biotechnology in india TITLE_IMG7 IMG_RES7
biotechnology in india TITLE_IMG8 IMG_RES8
biotechnology in india TITLE_IMG9 IMG_RES9
biotechnology in india TITLE_IMG10 IMG_RES10